News

Providence provides $2.1 billion in community benefit in 2025 to address and respond to the community’s greatest needs

Adoptive cell therapy: Phase III study open for people with advanced melanoma

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

Providence to participate in federally funded research for early detection of a behavioral health crisis

Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.

Providence’s Dr. Brian Chesebro named ‘Visionary Changemaker’ for environmental stewardship

Brian Chesebro, M.D. received the 2026 Visionary Changemaker award for his leadership driving innovation in healthcare sustainability and emissions reduction.

It started with one bandage, and a patient’s smile

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New guidelines for treating head and neck cancer could be a game changer

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

Communities invest nearly $500 million in 2025 to Providence philanthropy, new report shows

More than 40,000 donors to Providence foundations fund critical research, clinical breakthroughs, patient support services and technological advances in communities across the Western U.S.

New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

VOICES of Black Women: A community study in cancer prevention and care

A new study focused on stories will change health outcomes for Black women.

Leading the way: Providence researchers at AACR Annual Meeting

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.

Providence reports year-end 2025 results

Providence, a not-for-profit health system serving the Western U.S., has announced results for the fiscal year ended December 31, 2025.

Providence publishes environmental strategies for information services teams

Providence has released a toolkit to guide other organizations in using technology to support environmental stewardship efforts.

Celebrating oncology social workers: Compassion, expertise and impact

We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.

Providence explores strategic options, sale of Providence Health Plan

Providence today announced it is actively exploring strategic options for Providence Health Plan (PHP) – including the sale of the plan.

Providence CFO Greg Hoffman announces retirement

Chief Financial Officer Greg Hoffman has announced plans to retire in June. His decision comes at a moment of strengthening performance and growing financial stability across Providence.

Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations

Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients

Clinical trial seeks better first-line therapy for follicular lymphoma

The study may redefine care for many people at the earliest stage of their treatment.